Steatotic liver disease (commonly called fatty liver disease) progresses silently. Even in the absence of noticeable symptoms ...

Research finds that TyGWHtR, a simple metabolic index, predicts non-alcoholic fatty liver disease in older adults, ...

Chronic liver disease (CLD) is responsible for significant morbidity and mortality. Most liver-related outcomes occur in people with advanced CLD, yet liver disease can be asymptomatic until the late ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted 510(k) clearance to Nanox’s HealthFLD artificial intelligence software to aid clinicians in ...

Myosteatosis, the pathological infiltration of fat into skeletal muscle, is increasingly recognized as a key predictor of ...

Digital pathology assisted by artificial intelligence (AI) has the potential to transform the diagnosis and treatment of fibrotic liver disease in the next few years and to reshape clinical trials, ...

Myosteatosis is associated with poor outcomes in various liver diseases. However, standardized methods for assessing, defining, and diagnosing myosteatosis in the context of liver diseases remain ...

People with compromised liver function may be able to reduce their risk of liver cancer or slow its progression with a simple ...

New analysis shows alcohol-related liver disease remains a major cause of cirrhosis and liver death. Read more.

The liver stands as one of the body’s most resilient organs, capable of remarkable regeneration even after sustaining significant damage from years of alcohol consumption. This vital organ, ...